Verdezyne To Build and Operate World’s First Bio-Based DDDA Plant in Malaysia

Agreement with Bio-XCell to Finance and Build Verdezyne’s Commercial Plant with Annual Production Capacity of 30 Million Pounds of Diacids includes $75 Million in Financing, 20,000-Square-Foot Facility, and All Major Utilities Exchange of Agreement Ceremony Attended by Malaysian Prime Minister Najib Razak CARLSBAD, Calif. & KUALA LUMPUR, Malaysia, November 19, 2014 – Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, today announced it has reached an agreement with Bio-XCell Malaysia to construct Verdezyne’s first commercial-scale renewable chemicals manufacturing facility in Bio-XCell’s premier biotechnology and ecosystem park in Nusajaya, Iskandar, in southern Malaysia. With construction scheduled to commence in 2015, the plant will be capable of producing approximately 30 million pounds per year of diacids, including dodecanedioic acid (DDDA), and will be the world’s first bio-based plant for the production of DDDA. The exchange of agreement ceremony took place during the official opening ceremony of “BioMalaysia: Bioeconomy Asia Pacific 2014 Conference & Exhibition,” and was attended by Malaysian Prime Minister Najib Razak.
But Palmary Chemical used Microbial Fermentation Technology Patent to produce DDDA in China. our quality will be more stable and enviromental protection too.
For more information please refer to the individual technical data sheet or contact PALMARY CHEMICAL by email ([email protected]) or SKYPE ID: palmarychem

【 Go Back 】 | 【 Print 】